🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Severe Bacterial Infections

A Phase I Study of QLS12010 Capsules: Safety, Tolerability, PK, PD, and Food Effects in Healthy Adults and Moderate to Severe Atopic Dermatitis Patients NCT06946641Phase 11 site📍 Beijing Shanghai Qilu Pharmaceutical Research and Development Cente… · Tests: QLS12010, Placebo Fosfomycin I.v. for Treatment of Severely Infected Patients NCT02979951n/a50 sites📍 Hall in Tirol📍 Reutte📍 Vienna Infectopharm Arzneimittel GmbH Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe HS Within the Italian Population NCT07543419n/a16 sites📍 Ancona📍 Bari📍 Brescia Novartis Pharmaceuticals Safety and Efficacy of Soquelitinib in Adults With Hidradenitis Suppurativa NCT07828860Phase 111 sites📍 West Lafayette📍 Bowling Green📍 Owensboro Corvus Pharmaceuticals, Inc. · Tests: Soquelitinib A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa NCT07225569Phase 286 sites📍 Scottsdale📍 North Hollywood📍 Boynton Beach Sanofi · Tests: SAR445399, Placebo Identification of Clinical, Genetic and Immunological Factors Involved in the Development of Severe Bacterial Infections in Pediatrics NCT07111793NA7 sites📍 Nantes📍 Brest📍 Lyon Nantes University Hospital · Tests: Extended phenotyping, Blood sample for WES, Blood sample for PBMC freezing, POPC score evaluation, Questionnaire comple… Epidemiological, Clinical and Biological Characteristics of Human Anaplasmosis Cases in Alsace NCT07312474n/a1 site📍 Strasbourg University Hospital, Strasbourg, France Optimising Kangaroo Care to Reduce Neonatal Severe Infection/Sepsis and Resistant Bacterial Colonisation Among High-risk Infants in NICU. NCT05993442NA24 sites📍 Athens📍 Attiki📍 Heraklion PENTA Foundation · Tests: Optimised kangaroo care Real-World Effectiveness of Benralizumab in Allergic Bronchopulmonary Aspergillosis NCT07530770n/a2 sites📍 Jinan📍 Jinan Qianfoshan Hospital · Tests: Fasenra A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab) NCT06888193Phase 114 sites📍 Santa Monica📍 South Miami📍 Boston UCB Biopharma SRL · Tests: Bimekizumab The DECIDE-TB Trial; Validation of Treatment Decision Algorithms for Childhood Tuberculosis NCT06593080NA29 sites📍 Chingola📍 Chingola📍 Chingola Chishala Chabala · Tests: The comprehensive TDA based approach Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a2 sites📍 Sioux Falls📍 Sydney Sanford Health A Study of Zasocitinib in Adults With Hidradenitis Suppurativa NCT07244263Phase 249 sites📍 Scottsdale📍 Fort Smith📍 Fountain Valley Takeda · Tests: Zasocitinib (Dose A), Placebo Efficacy, Safety, and Tolerability of HB0043 in Hidradenitis Suppurativa Patients. NCT06895499Phase 1, Phase 21 site📍 Jinan Shanghai Huaota Biopharmaceutical Co., Ltd. · Tests: HB0043, HB0043, HB0043 Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research NCT04806620n/a1 site📍 Delafield Brain Inflammation Collaborative Treating Severe Mitral Valve Annular or Valvular Calcification Using Shockwave Balloon SMARTWAVE NCT06952374NA1 site📍 Shatin Prince of Wales Hospital, Shatin, Hong Kong · Tests: SmartWave Lithotripsy balloon Real-world Secukinumab Outcomes in Canadian HS Patients NCT07282015n/a15 sites📍 Calgary📍 Calgary📍 Winnipeg Novartis Pharmaceuticals Monocyte Profiles in Critically Ill Patients With Pseudomonas Aeruginosa Sepsis NCT03044223n/a1 site📍 Ulm University of Ulm Atmospheric Pressure Cold Plasma for Moderate-to-severe Tinea Pedis NCT07056660NA1 site📍 Luoyang Shenyang Medical College · Tests: Active CAP therapy, Sham CAP therapy, standard care Secukinumab Treatment for Moderate to Severe Hidradenitis Suppurativa NCT07109765n/a1 site📍 Beijing Peking Union Medical College · Tests: Secukinumab A Proof-of-Concept Study of LAD328 in Adults With Hidradenitis Suppurativa NCT07547813Phase 21 site📍 Warsaw Almirall, S.A. · Tests: LAD328, Placebo Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective NCT07358910n/a1 site📍 Phnom Penh Institut Pasteur du Cambodge Opportunistic Pneumococcal Immunisation Trial in MALnutrition NCT06817421Phase 41 site📍 Dili Nick Fancourt · Tests: Pneumococcal conjugate vaccine, Typhoid conjugate vaccine Frequency of SPAD in Adult Patients NCT05664035n/a1 site📍 Lille University Hospital, Lille · Tests: Diagnosis of SPAD using immunization with PPV23 A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab NCT06524635Phase 22 sites📍 Sacramento📍 Ann Arbor AbbVie · Tests: Lutikizumab Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa NCT07213973Phase 230 sites📍 Birmingham📍 Phoenix📍 Phoenix Incyte Corporation · Tests: Povorcitinib Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT 2 NCT04678154Phase 331 sites📍 Redwood City📍 San Francisco📍 San Francisco Major Extremity Trauma Research Consortium · Tests: Standard of care, Vancomycin and Tobramycin ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis Suppurativa NCT07783542Phase 215 sites📍 Birmingham📍 Fountain Valley📍 Los Angeles Oruka Therapeutics, Inc. · Tests: ORKA-002, Placebo CommunautAry Pediatric bacteRial Infection in Intensive CarE Unit NCT06260345n/a1 site📍 Créteil Association Clinique Thérapeutique Infantile du val de Marne A Study to Explore the Tissue Level Effects of Remibrutinib in Adults With Moderate to Severe HS NCT07855276Phase 11 site📍 Mayfield Heights Novartis Pharmaceuticals · Tests: LOU064, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy